AI-generated summary
The authors randomly assigned 180 inpatients with bipolar depression to daily bright light therapy plus medication or to medication alone for four weeks, then assessed irritability. They report about one-third fewer irritability cases in the light therapy group, a reduction not linked to overall depression remission. The authors describe the findings as supporting a possible role for bright light therapy in irritability, which is a single-blind trial with a qualitative assessment.
- Participants
- 180
- Who or what was studied
- Inpatients with bipolar depression
- Limits stated in the abstract
- The abstract describes a single-blind design with a qualitative assessment of irritability and does not report effect sizes or statistical tests.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.